Document is current
Any future updates will be listed below
-
Authors
Hingorani, Sangeeta https://orcid.org/0000-0003-3743-1325
Gibson, Keisha L.
Xie, Yuping
Wang, Yujie
Eddy, Sean
Hartman, John
Sampson, Matthew
Cassol, Clarissa
Thomas, David
Gipson, Debbie S.
Trachtman, Howard
Srivastava, Tarak
Reidy, Kimberly
,
Massengill, S.
Lo, L.
Dell, K.
Sedor, J.
Martin, B.
Lemley, K.
Fajardo, C.
Sharma, S.
Srivastava, T.
Markus, K.
Sethna, C.
Vento, S.
Canetta, P.
Pradhan, A.
Gbadegesin, R.
Olabisi, O.
Greenbaum, L.
Wang, C. S.
Yun, E.
Adler, S.
LaPage, J.
Amarah, A.
Itteera, M.
Atkinson, M.
Williams, M.
Fervenza, F.
Hogan, M.
Lieske, J.
Selewski, D.
Conley, C.
Kaskel, F.
Ross, M.
Flynn, P.
Kopp, J.
Malaga-Dieguez, L.
Zhdanova, O.
Pehrson, L. J.
Almaani, S.
Price, C.
Lafayette, R.
Dave, S.
Lee, I.
Pfeiffer, Z.
Shah, S.
Deslandes, A.
Reich, H.
Hladunewich, M.
Ling, P.
Romano, M.
Brakeman, P.
Podoll, A.
Rogers, N.
McCarthy, E.
Landry, E.
Fornoni, A.
Bidot, C.
Kretzler, M.
Gipson, D.
Williams, A.
Stelzer, M.
Nachman, P.
Rheault, M.
Rajala, S.
Derebail, V.
Gibson, K.
Froment, A.
Ochoa-Toro, F.
Holzman, L.
Meyers, K.
Kallem, K.
Edwards, A.
Sharma, K.
Sambandam, K.
Robles, E.
Turk, M.
Jefferson, A.
Hingorani, S.
Tuttle, K.
Manahan, L.
Pao, E.
Kuykendall, K.
Lin, J. J.
Cody, E.
-
Funding
Funding for this research was provided by:
NIDDK (U54DK083912)
- License Information
-
More Information
Article History
Received: 6 July 2022
Revised: 22 November 2022
Accepted: 22 December 2022
First Online: 4 May 2023
Declarations
:
: SH is a consultant for Omeros though this is not relevant to this work<b>.</b> KR is a site investigator for Travere and Advicienne supported clinical trials. DG has no disclosures relevant to this work. TS is a site investigator for Bristol-Myers-Squibb, Apellis Pharmaceuticals, and Travere Therapeutics. MGS is on the Scientific Advisory Board of Natera and a consultant for Maze.
